What happens when you increase your Mounjaro dose

The decision to step up: what a prescriber is weighing up

Moving to a higher Mounjaro dose is not automatic. Your prescriber looks at two things above everything else: how well you've tolerated the current dose, and whether your weight loss is tracking in the right direction. The standard titration ladder runs 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, with roughly four weeks at each level before any increase is considered. That four-week window is not arbitrary, it gives your digestive system time to adapt to the new level of gastric slowing.

If side effects at your current dose are still intrusive after four weeks, stepping up too soon tends to compound them. A prescriber may hold you at the current strength for another month rather than push forward. Equally, if you're losing weight steadily and tolerating treatment well, there may be no clinical reason to increase at all, some people reach a comfortable, effective dose well below 15 mg. Understanding when a dose increase is genuinely indicated helps frame the conversation with your clinical team.

At nume, a named clinician reviews your progress before every repeat order. There is no automated step-up; the decision sits with the prescriber, not a system.

What your body goes through in the first two weeks after a step-up

The most predictable pattern after a dose increase is a short-lived return of GI symptoms. Nausea is the most frequently reported; loose stools, burping, and a feeling of fullness after very small amounts of food also come up often. For most people these ease within one to two weeks as the body adjusts to the stronger signal. Fatigue and mild headache can also appear around the time of the first injection at the new dose.

One practical habit worth building: for the two days after your first injection at a new strength, keep a brief note of how you feel (morning energy, appetite, any nausea) so you have something concrete to tell your prescriber if they ask. It takes under a minute and gives the clinical team real information to work with rather than a general impression.

The NHS patient-level information on tirzepatide outlines the full side-effect profile in plain language. Severe, persistent stomach pain that radiates to the back is a reason to seek urgent medical help rather than wait for the next scheduled check-in, this can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as a known but infrequent risk with GLP-1 medicines.

Why weight loss often accelerates, and what that actually means

Many people notice a more pronounced drop in appetite in the first week or two after stepping up. Hunger cues become quieter; portion sizes that felt small before start to feel sufficient. This is the mechanism working as intended: tirzepatide acts on both GIP and GLP-1 receptors, reinforcing signals of fullness and slowing the rate at which your stomach empties food. A stronger dose delivers a stronger version of that signal.

In the SURMOUNT-1 trial, participants reaching 15 mg saw average body-weight reductions of around 20 to 21 percent over 72 weeks, compared with around 15 percent in those on lower maintenance doses, the higher the tolerated dose, the greater the average loss, as reported in the New England Journal of Medicine's SURMOUNT-1 paper. That trial enrolled around 2,500 adults with obesity. Figures like these describe group averages in a controlled trial; your result depends on the dose you reach, your adherence, and the lifestyle changes you make alongside treatment.

For context on what it looks like to reach the ceiling of treatment, the 15 mg endpoint has its own practical considerations that are worth reading before you get there. Information on the 5 mg step specifically is also available if that is where you currently are in the titration schedule.

Practical steps to manage a dose increase well

Three things consistently help people through a step-up. First, food choices matter more than usual in the week after an increase: smaller, lower-fat meals put less demand on a stomach that is already emptying slowly. Second, hydration. Nausea from GLP-1 medicines is worsened by dehydration, and if vomiting or diarrhoea occurs it compounds quickly, sipping water steadily through the day is not glamorous advice but it works. Third, timing. Some people find moving their injection to a day when they can rest the following morning takes the edge off the first few days at a new dose; discuss this with your prescriber before changing your injection day, since spacing matters.

If you miss an injection during a step-up period, the approach differs from a missed dose at a stable level, details on how to handle a missed Mounjaro injection are covered separately. Taking a double dose to compensate is not appropriate; the clinical reasoning behind that is explained on a dedicated page. Both scenarios are ones your prescriber or pharmacist should know about.

If you are thinking about starting treatment or want clinical guidance on your current titration, the team at our prescribing service reviews consultations the same day. Speak to our prescribers to discuss what the right next step looks like for you specifically.